Free Trial

Kimelman & Baird LLC Has $318,000 Position in Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background
Remove Ads

Kimelman & Baird LLC trimmed its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 63.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,500 shares of the company's stock after selling 6,000 shares during the period. Kimelman & Baird LLC's holdings in Colgate-Palmolive were worth $318,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Kohmann Bosshard Financial Services LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $26,000. Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive during the 4th quarter worth $27,000. Union Bancaire Privee UBP SA bought a new stake in Colgate-Palmolive during the fourth quarter valued at about $32,000. Briaud Financial Planning Inc acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $32,000. Finally, Wintrust Investments LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth about $33,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Barclays decreased their target price on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research note on Friday, January 17th. UBS Group lowered their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research note on Monday, February 3rd. StockNews.com cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Friday, March 14th. Royal Bank of Canada restated a "sector perform" rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, Raymond James reaffirmed an "outperform" rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $101.72.

Remove Ads

Check Out Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Trading Up 0.0 %

NYSE CL traded up $0.02 during trading hours on Friday, hitting $90.30. The company's stock had a trading volume of 8,950,637 shares, compared to its average volume of 4,222,165. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The firm has a market capitalization of $73.28 billion, a P/E ratio of 25.65, a PEG ratio of 4.20 and a beta of 0.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock has a fifty day moving average of $89.25 and a 200 day moving average of $94.38.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company posted $0.87 EPS. Equities research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive declared that its Board of Directors has authorized a share repurchase program on Thursday, March 20th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the company to repurchase up to 6.8% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.30%. The ex-dividend date of this dividend is Thursday, April 17th. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio is presently 56.82%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads